Adrenoleukodystrophy (ALD)
3 clinical trials · Condition
◉ Watch Adrenoleukodystrophy (ALD)
| Record | Firm | Date |
|---|---|---|
| Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product (NCT02698579) | Genetix Biotherapeutics Inc. | 2016-01-22 |
| Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders (NCT01043640) | Masonic Cancer Center, University of Minnesota | 2009-12-01 |
Track Adrenoleukodystrophy (ALD) automatically
Every clearance here is in the API, with alerts when new ones post.